Showing results (1711-1720 of 2,364) with videos related to

Sort By:
Pageof 237
Circulation. Cardiovascular Interventions|January 1, 2017
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary InterventionNeal N Sawlani, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology|January 10, 2015
Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trialsGregg W Stone, Roxana Mehran, Patrick Goldstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 25, 2020
Bioresorbable vascular scaffolds versus everolimus-eluting stents: a biomechanical analysis of the ABSORB III Imaging substudyArnav Kumar, Bill D Gogas, Elizabeth W Thompson, et al.
JAMA Surgery|October 30, 2024
Time Since Prior NSTEMI and Major Adverse Cardiovascular and Cerebrovascular Events After Noncardiac SurgeryLaurent G Glance, Karen E Joynt Maddox, Sabu Thomas, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|June 18, 2023
Validation of American Society of Echocardiography Guideline-Recommended Parameters of Right Ventricular Dysfunction Using Artificial Intelligence Compared With Cardiac Magnetic Resonance ImagingBrian C Hsia, Ashton Lai, Supreet Singh, et al.
Circulation. Population Health and Outcomes|August 5, 2026
Assessing the Prognostic Value of Serial Seattle Angina Questionnaire Scores in Chronic Coronary DiseaseEvan L O'Keefe, John T Saxon, Yoon Joo Cho, et al.
American Heart Journal|February 15, 2011
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialAdriano Caixeta, George D Dangas, Roxana Mehran, et al.
The New England Journal of Medicine|January 21, 2011
A prospective natural-history study of coronary atherosclerosisGregg W Stone, Akiko Maehara, Alexandra J Lansky, et al.
Circulation. Cardiovascular Interventions|April 14, 2020
Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease: An Individual Patient-Level Pooled Analysis of 19 Randomized Coronary Stent TrialsMahesh V Madhavan, Björn Redfors, Ziad A Ali, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 5, 2017
Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trialsCarlos M Campos, Adriano Caixeta, Marcelo Franken, et al.
Pageof 237